These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6976462)

  • 1. [Localized scleroderma and PSS specific anti-Og antibody (author's transl)].
    Nishikawa T; Kurihara S; Sugiura M; Shimizu H; Tojo T
    Nihon Hifuka Gakkai Zasshi; 1981 Jul; 91(8):859-60. PubMed ID: 6976462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Scleroderma in children (author's transl)].
    Posternak F; Orusco M
    Schweiz Rundsch Med Prax; 1974 Jul; 63(30):913-21. PubMed ID: 4547092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scleroderma in plaques. Immunological and visceral disturbances (author's transl)].
    Bourgeois-Droin C; Touraine R
    Ann Med Interne (Paris); 1978 Feb; 129(2):107-12. PubMed ID: 305741
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma.
    Takehara K; Kikuchi K; Soma Y; Igarashi A; Ishibashi Y
    Arch Dermatol; 1990 Oct; 126(10):1368. PubMed ID: 2221947
    [No Abstract]   [Full Text] [Related]  

  • 6. [DNA antibody determination in diffuse connective-tissue disease (author's transl)].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1626-7. PubMed ID: 4602107
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antinuclear antibodies in localized scleroderma].
    Takehara K; Nakabayashi Y; Ishibashi Y; Moroi Y
    Nihon Hifuka Gakkai Zasshi; 1982; 92(8):883-8. PubMed ID: 6816966
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads.
    Kikuchi K; Takehara K; Ishibashi Y
    J Am Acad Dermatol; 1989 Dec; 21(6):1301-3. PubMed ID: 2685065
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 10. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications of the systemic character of circumscript scleroderma in children and adolescents].
    Albrecht-Nebe H; Eggert W; Ziegler H; Barthelmes H; Wolf S
    Dermatol Monatsschr; 1987; 173(3):123-30. PubMed ID: 3496247
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Serologic abnormalities and their significance in localized scleroderma.
    Scarola JA; Shulman LE
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
    Asano Y; Sato S
    Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic abnormalities in localized scleroderma].
    Takehara K; Nakabayashi Y; Ishibashi Y; Moroi Y; Aikawa T; Inaba K; Meshizuka K
    Nihon Hifuka Gakkai Zasshi; 1984 Feb; 94(2):121-8. PubMed ID: 6610780
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.
    Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K
    Rheumatology (Oxford); 2001 Jun; 40(6):683-6. PubMed ID: 11426027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized scleroderma is an autoimmune disorder.
    Takehara K; Sato S
    Rheumatology (Oxford); 2005 Mar; 44(3):274-9. PubMed ID: 15561734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.